itraconazole and Communicable Diseases

itraconazole has been researched along with Communicable Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bottero, J; Fournier, S; Gallien, S; Molina, JM; Porcher, R; Ribaud, P; Socié, G; Sulahian, A1
Brunet, J; Cancelas, JA; López-López, JJ; Maroto, P; Mendoza, L; Montesinos, J; Ojeda, B; Rodríguez, M; Salazar, R; Solá, C; Tabernero, JM; Valentí, V; Verger, G1

Reviews

1 review(s) available for itraconazole and Communicable Diseases

ArticleYear
Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases.
    Infection, 2008, Volume: 36, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Communicable Diseases; Female; Hospital Units; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Paris; Prognosis; Risk Factors; Treatment Outcome; Young Adult

2008

Other Studies

1 other study(ies) available for itraconazole and Communicable Diseases

ArticleYear
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
    Bone marrow transplantation, 1999, Volume: 23, Issue:1

    Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Ciprofloxacin; Combined Modality Therapy; Communicable Diseases; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Itraconazole; Male; Middle Aged; Neoplasms; Prospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Transplantation, Autologous; Treatment Outcome

1999